Stocks
Cassava Sciences Inc (SAVA) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -4.57 | -6.31 | -31.9 | -74.9 | -95.7 | -133.5 | ||
| Changes by years, y/y, % | -31% | +38% | +405% | +135% | +28% | +70.4% | |||
Cassava Sciences Inc. EBITDA US GAAP, bln rub
Cassava Sciences Inc. EBITDA US GAAP, changes, %
Cassava Sciences Inc. EBITDA US GAAP, sum by quarters, bln rub
Cassava Sciences Inc (SAVA) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -27.5 | -22.4 | -19.6 | -61.1 | -30.4 | -133.5 | |
| Changes by years, y/y, % | +29% | +7% | -26% | +112% | +10% | |||
| Changes by quarters, q/q, % | -4% | -18% | -13% | +211% | -50% | |||
